Results of Nurse Navigator Follow-up After Positive Colorectal Cancer Screening Test: A Randomized Trial

References

1. 1.↵
   1. Whitlock EP,
   2. Lin JS,
   3. Liles E,
   4. Beil TL,
   5. Fu R

   . Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638–58.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use–United States, 2012. MMWR Morb Mortal Wkly Rep 2013;62:881–8.

   OpenUrlPubMed
3. 3.↵
   1. Hardcastle JD,
   2. Chamberlain JO,
   3. Robinson MH,
   4. et al

   . Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Mandel JS,
   2. Church TR,
   3. Ederer F,
   4. Bond JH

   . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434–7.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Kronborg O,
   2. Fenger C,
   3. Olsen J,
   4. Jorgensen OD,
   5. Sondergaard O

   . Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Myers RE,
   2. Turner B,
   3. Weinberg D,
   4. et al

   . Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings. Prev Med 2001;33:249–60.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Lurie JD,
   2. Welch HG

   . Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst 1999;91):1641–6.
8. 8.↵
   1. Baig N,
   2. Myers RE,
   3. Turner BJ,
   4. et al

   . Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 2003;98:2078–81.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Ferrat E,
   2. Le Breton J,
   3. Veerabudun K,
   4. et al

   . Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer 2013;109:1437–44.

   OpenUrlPubMed
10. 10.↵
    1. Torring ML,
    2. Frydenberg M,
    3. Hamilton W,
    4. Hansen RP,
    5. Lautrup MD,
    6. Vedsted P

    . Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol 2012;65:669–78.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Thomson CS,
    2. Forman D

    . Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 2009;101(Suppl 2):S102–9.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Kravitz RL,
    2. Rolph JE,
    3. Petersen L

    . Omission-related malpractice claims and the limits of defensive medicine. Med Care Res Rev 1997;54:456–71.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Wallace E,
    2. Lowry J,
    3. Smith SM,
    4. Fahey T

    . The epidemiology of malpractice claims in primary care: a systematic review. BMJ Open 2013;3. pii: e002929.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Green BB,
    2. Wang CY,
    3. Horner K,
    4. et al

    . Systems of Support to Increase Colorectal Cancer Screening and Follow-up Rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials 2010;31:589–603.

    OpenUrlPubMed
15. 15.↵
    1. Green BB,
    2. Wang CY,
    3. Anderson ML,
    4. et al

    . An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med 2013;158(5 Pt 1):301–11.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Miglioretti DL,
    2. Rutter CM,
    3. Bradford SC,
    4. et al

    . Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care 2008;46(9 Suppl 1):S91–6.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Wagner EH,
    2. Austin BT,
    3. Von Korff M

    . Organizing care for patients with chronic illness. Milbank Q 1996;74:511–44.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Raich P,
    2. Whitley E,
    3. Thorland W,
    4. Valverde P,
    5. Faircloth D

    ; Denver Patient Navigation Research Program. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev 2012;21:1629–38.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Wells KJ,
    2. Lee JH,
    3. Calcano ER,
    4. et al

    . A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev 2012;21:1664–72.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Paskett ED,
    2. Katz ML,
    3. Post DM,
    4. et al

    . The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev 2012;21:1620–8.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Humphrey LL,
    2. Shannon J,
    3. Partin MR,
    4. O'Malley J,
    5. Chen Z,
    6. Helfand M

    . Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med 2011;26:691–7.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Myers RE,
    2. Turner B,
    3. Weinberg D,
    4. et al

    . Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 2004;38:375–81.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Singh H,
    2. Kadiyala H,
    3. Bhagwath G,
    4. et al

    . Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol 2009;104:942–52.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Heitman SJ,
    2. Ronksley PE,
    3. Hilsden RJ,
    4. Manns BJ,
    5. Rostom A,
    6. Hemmelgarn BR

    . Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009;7:1272–8.

    OpenUrlCrossRefPubMed